You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康-B(6606.HK)大漲20%股價創2個半月新高 本週已累漲超50%
格隆匯 06-23 14:08
格隆匯6月23日丨諾輝健康-B(6606.HK)高開高走,現大漲20.25%報22.8港元,股價創2個半月新高,暫成交9173萬港元,最新市值98億港元;該股近期持續走強,本週迄今已四日連升累漲超50%。諾輝健康本週一(20日)晚間宣佈,選舉公司執行董事兼CEO朱葉青先生為董事長兼CEO,全面領導諾輝健康邁入癌症早篩科技創新和商業化的新徵程。原諾輝健康董事長陳一友博士任公司執行董事兼首席科學官,加速推進公司內部和外部研發計劃。此前6月8日,諾輝健康攜手Prenetics Group Limited在香港舉辦常衞清(ColoClear by Circle)產品上市發佈會。諾輝健康CEO朱葉青宣佈公司正在香港籌建諾輝健康的首個國際研發中心,聚焦於包括二代測序技術(NGS)的多組學(multi-omics)癌症篩查技術創新和產品開發。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account